Home/Filings/4/0000950170-24-137889
4//SEC Filing

Manning Paul B 4

Accession 0000950170-24-137889

CIK 0001841387other

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 4:11 PM ET

Size

7.9 KB

Accession

0000950170-24-137889

Insider Transaction Report

Form 4
Period: 2024-12-16
Transactions
  • Purchase

    Common Stock

    2024-12-16$6.00/sh+750,000$4,500,0001,303,752 total(indirect: By LLC)
  • Purchase

    Common Stock

    2024-12-16$6.00/sh+500,000$3,000,0001,142,406 total(indirect: By Trust)
Holdings
  • Common Stock

    1,681,000
Footnotes (3)
  • [F1]The shares are held by The Paul B. Manning Revocable Trust dated May 10, 2000 (the "Trust"). The Reporting Person is the trustee of the Trust and has sole voting and investment power with respect to the shares held by the Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  • [F2]The shares are held directly by BKB Growth Investments, LLC ("BKB"). The Reporting Person is a co-manager of Tiger Lily Capital, LLC, the manager of BKB, and has shared voting and investment power with respect to the shares held by BKB. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
  • [F3]Includes shares held jointly with spouse.

Documents

1 file

Issuer

Candel Therapeutics, Inc.

CIK 0001841387

Entity typeother

Related Parties

1
  • filerCIK 0001494695

Filing Metadata

Form type
4
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 4:11 PM ET
Size
7.9 KB